Drugs, food, and weight! Oh my!

A new class of medicines, like Ozempic, have shown tremendous benefit in helping people manage a number of diseases, including diabetes and obesity. Where efforts to improve public health through diet alone have fallen flat, there is hope that these new medicines, called GLP-1s, may usher in a new era of positive public health outcomes. Dr. Dariush Mozaffarian, Director, Food is Medicine Institute, Tufts University, and a recognized expert in nutrition and public health, will share insight about the potential promise of these drugs and how they can be combined with changes in diet, alongside broader efforts to reform food policy.